Navigation Links
Amira Announces AM103 and AM803 Patent Grant in the United Kingdom
Date:7/13/2010

SAN DIEGO, July 13 /PRNewswire/ -- Amira Pharmaceuticals, Inc. today announced that the U.K. Intellectual Property Office has granted patent number GB2431927, titled, "5-Lipoxygenase Activating Protein (FLAP) Inhibitors," which includes coverage of Amira's AM103 and AM803 FLAP inhibitors for the treatment of respiratory disorders.

In January 2008, Amira and GlaxoSmithKline (GSK) entered into a worldwide exclusive agreement allowing GSK to develop, manufacture and commercialize specified FLAP inhibitors for the treatment of respiratory and cardiovascular disease.  AM803 was added to the license agreement later in 2008.  GSK is currently conducting Phase 2 clinical trials in respiratory disorders with an Amira-licensed FLAP inhibitor.

"Amira continues to be successful in obtaining patent coverage for compounds being advanced in clinical trials," said John Hutchinson, Ph.D., Vice President of Chemistry.  "This patent covering both AM103 and AM803 is the third issued this year, following two patents related to our DP2 receptor antagonists granted by the United Kingdom."  Bob Baltera, Chief Executive Officer of Amira, added, "This patent relates to some of the first compounds developed by Amira.  It reflects our ongoing objective to secure strong patent protection around each of our development programs."

The newly granted claims cover novel inhibitors of the FLAP protein.  The patent also discloses uses of FLAP inhibitors for the treatment of inflammatory diseases such as asthma, cardiovascular disease, dermatological disorders and ocular diseases.

About Amira

Founded in 2005 and headquartered in '/>"/>

SOURCE Amira Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Amira Announces Second DP2 Antagonist Patent Grant in the United Kingdom
2. Anti-Fibrotic Data from Amira Pharmaceuticals LPA1 Receptor Antagonist Program Published in the British Journal of Pharmacology
3. Amira Pharmaceuticals Announces Efficacy of LPA1 Antagonist in a Preclinical Model of Scleroderma
4. Amira Pharmaceuticals Announces Initial Positive Phase 1 Clinical Data for AM461, A Back-Up to Amiras Lead DP2 Antagonist, AM211
5. Amira Pharmaceuticals Submits IND for Second DP2 Antagonist, AM461
6. Hanger Orthopedic Group, Inc. Announces Second Quarter 2010 Earnings Release Conference Call
7. K-V Pharmaceutical Announces Resubmission to New Drug Application for Gestiva™
8. Rcadia Announces Five COR Analyzer® Studies to be Presented at SCCT Annual Scientific Meeting
9. Medical Alarm Concepts™ Announces Roll-Out of the MediPendant™ at Albertsons
10. Biovista Announces the Appointment of Clifford H. Farrah to its Advisory Board
11. Telik Announces Publication of Review Focused on the Inhibition of the Enzyme GSTP1-1 as a Target for New Cancer Treatments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... HOUSTON , Aug. 21, 2014   Memorial Hermann ... Anderson Cancer Center today announced a new partnership to ... network of community breast care centers in the greater ... November, MD Anderson will become the exclusive provider of professional ... care centers, located in Memorial City, The Woodlands ...
(Date:8/21/2014)... Texas , Aug. 21, 2014  eRelevance ... services company, announced today that it has completed ... (EMR) solution for Plastic Surgery and Dermatology practices. ... even more value to healthcare practices using Nextech," ... of eRelevance Corporation. "Using information from the EMR ...
(Date:8/21/2014)... 2014 /CNW/ - Eisai Limited is pleased to support the ... comic book available in Canada . The ... to educate children and their parents about epilepsy, the most ... more than 300,000 Canadians. Eisai is guided by a corporate ... which the patient is central – there was a need ...
Breaking Medicine Technology:Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 2Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 3Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 4eRelevance Corporation Integrates with Nextech Electronic Medical Records 2Eisai Pleased to Support Canadian Epilepsy Alliance Comic Book that Teaches Children About Epilepsy 2
... ULURU Inc. (NYSE Alternext: ULU) today announced ... third quarter ended September 30, 2009 financial results and provide ... 9:00 a.m. Eastern Time. , To participate in the conference ... 429-1388 (access code 23511#) five to ten minutes prior to ...
... Nov. 3 Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHMD ) ... notice from the NASDAQ Market Listing Qualifications Department stating that ... for the continued listing of its common stock on the ... 5550(a)(2). , Pursuant to NASDAQ,s rules, Peregrine was required to ...
Cached Medicine Technology:ULURU Inc. Announces Conference Call to Discuss Financial Results for the Third Quarter Ended September 30, 2009 and to Provide a Business Update 2Peregrine Pharmaceuticals Regains Full Compliance With Nasdaq Continued Listing Requirements 2
(Date:8/22/2014)... Centennial, CO (PRWEB) August 22, 2014 ... leading provider of in-home care for seniors, is proud ... Longevity Webinar Series. The upcoming webinar will feature Dr. ... Health at Lenox Hill Hospital in New York City, ... Campaign, and author. The webinar will cover the issues ...
(Date:8/22/2014)... -- College can be a challenging time for young people, ... to make the most of their new life, an expert ... new people and learn to manage the temptations of new ... at St. John,s University in New York City, said in ... in the classroom. College is a time when students transition ...
(Date:8/22/2014)... York, NY (PRWEB) August 22, 2014 ... jewelry is now offering 60-80% off on its range ... saving on the purchase of Gold Hearts 14K White ... offering at a discount of 77%. Previously priced ... at only $859.00. The item code of this mesmerizing ...
(Date:8/22/2014)... According to the new research report "Isocyanate ... & Forecast to 2019" defines and segments the ... the market value. The isocyanate material market value ... a significant CAGR from 2014 to 2019. , ... spread through 286 pages and in-depth TOC on ...
(Date:8/22/2014)... fainting. Each year approx. 265,000 Danes are acutely admitted ... research from Aarhus University and Aarhus University Hospital now ... every fourth patient are sent home again without ... to the acute hospitalisation., "Naturally, there is no need ... disprove that there is a serious illness. So some ...
Breaking Medicine News(10 mins):Health News:Home Care Assistance of Centennial to Host Webinar on Heart Health, Featuring Dr. Suzanne Steinbaum 2Health News:Home Care Assistance of Centennial to Host Webinar on Heart Health, Featuring Dr. Suzanne Steinbaum 3Health News:College Prep 101 2Health News:ItsHot.com Now Offers 60-80% Discount on its Striking Collection of Diamond Heart Pendants 2Health News:Isocyanate Market An Industry Growing Steadily Projected to Grow $38,729 Million by 2019 - Report by MarketsandMarkets 2Health News:Isocyanate Market An Industry Growing Steadily Projected to Grow $38,729 Million by 2019 - Report by MarketsandMarkets 3Health News:Isocyanate Market An Industry Growing Steadily Projected to Grow $38,729 Million by 2019 - Report by MarketsandMarkets 4Health News:Many patients are discharged without a diagnosis 2
... March 18, 2010 -- The number of U.S. medical ... but not enough to significantly impact the shortage of ... Resident Matching Program report, 2,722 U.S. seniors at medical ... 3.4 percent increase from 2,632 in 2009. The internal ...
... In its 21-year history, under the guidance of more than 450 ... teenagers from 170 schools in the greater Los Angeles ... March 21 , 2,800 SRLA students and volunteer leaders will again ... of the program, SRLA,s mission is to challenge at-risk secondary students ...
... by immune cells during a bout of inflammatory ... regenerate. Yet people with inflammatory bowel diseases have ... a hyper-activation of growth in those same intestinal ... Medicine have identified a feedback loop involving a ...
... Strategies may be needed to promote well-being in pregnancy, researcher ... pregnancy may increase the risk that a baby will develop ... in asthma is not understood, but animal studies suggest that ... womb, the researchers noted. It is also known that asthma ...
... 18 Today the Minnesota State High School League and Take Heart™ Minnesota together ... (SCA). Their statewide effort "tips off" tonight with CPR training for more than 50 students on the ... , ... ...
... with cleft palates have made a promising breakthrough and the ... are the most common birth defect in Britain, with one ... surgery is required to correct the problem, and in addition ... adult. The preliminary results on a hydrogel material studied using ...
Cached Medicine News:Health News:Residency match results not encouraging for adults needing primary care 2Health News:Students Run LA Takes 40,000 Students Across the Marathon Finish Line Over Past 21 Years 2Health News:Students Run LA Takes 40,000 Students Across the Marathon Finish Line Over Past 21 Years 3Health News:Feedback loop explains inflammatory effect on intestinal lining 2Health News:Prenatal Stress May Boost Baby's Asthma Risk 2Health News:Prenatal Stress May Boost Baby's Asthma Risk 3Health News:Minnesota State High School League and Take Heart Minnesota Team Up to Save More Lives From Sudden Cardiac Arrest (SCA) 2Health News:Minnesota State High School League and Take Heart Minnesota Team Up to Save More Lives From Sudden Cardiac Arrest (SCA) 3Health News:Minnesota State High School League and Take Heart Minnesota Team Up to Save More Lives From Sudden Cardiac Arrest (SCA) 4Health News:Minnesota State High School League and Take Heart Minnesota Team Up to Save More Lives From Sudden Cardiac Arrest (SCA) 5Health News:Minnesota State High School League and Take Heart Minnesota Team Up to Save More Lives From Sudden Cardiac Arrest (SCA) 6Health News:Breakthrough for babies born with severe cleft palates after experiments at ISIS 2Health News:Breakthrough for babies born with severe cleft palates after experiments at ISIS 3
... The RSV OIA test features a ... your results. Approved for children under age ... provides an answer in just over 15 ... will enable you to decrease costs for ...
The GC OIA test is a rapid assay for the diagnosis of gonorrhea. Thermo solved the challenge of developing a specific rapid assay for Neisseria gonorrhea by using the proprietary ribosomal protein, ...
... test combines performance equivalence to 14-day viral culture ... B with a simple, easy-to-use test with results ... all the same procedural steps as our FLU ... decrease costs for unnecessary ancillary testing, improve appropriate ...
... test delivers excellent sensitivity and specificity for the ... easy-to-use test that provides an answer in 6 ... to provide improved patient care with a test ... Find out what value we bring to your ...
Medicine Products: